Morningstar
•
Nov 05, 2026
Viatris Inc.: Viatris Earnings: Business Tracking Well Across the Board, With Key Milestones Ahead
Summary
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Zoetis Inc.
Nov 06, 2026
•
ZTS
SMID November 2026 Pick List
Nov 06, 2026
•
CARR, CTVA, FLUT, AMCR, F, KHC, LVS, RIVN, O, BR, Q, CRWV, CTSH, LPLA, HONA, ON, PYPL, ZBH, RMD, BKR, OTIS, HSY, WSO, EXE, PCG, INVH, EIX, ALB, CPNG, MDLN
Analyst Report: Zoetis Inc.
Nov 06, 2026
•
ZTS
Analyst Report: AbbVie Inc
Nov 06, 2026
•
ABBV
Market Digest: FIS, MCD, SPGI, NUE, SMCI, APO, ABBV, PPC, APP
Nov 06, 2026
•
APO, FIS, APP, PPC, SMCI, SPGI, ABBV, NUE, MCD
